Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain | 22 | 2022 | 1689 | 2.260 |
Why?
|
Magnetic Resonance Imaging | 18 | 2021 | 1222 | 2.110 |
Why?
|
Cognitive Dysfunction | 13 | 2022 | 938 | 1.780 |
Why?
|
Gait | 6 | 2021 | 404 | 1.430 |
Why?
|
Hippocampus | 6 | 2020 | 276 | 1.330 |
Why?
|
Exercise | 6 | 2021 | 467 | 1.130 |
Why?
|
Cognition | 10 | 2022 | 1279 | 1.110 |
Why?
|
Alzheimer Disease | 15 | 2022 | 1942 | 1.030 |
Why?
|
Aged, 80 and over | 30 | 2022 | 4844 | 1.020 |
Why?
|
Postural Balance | 3 | 2021 | 121 | 0.950 |
Why?
|
Aging | 8 | 2021 | 1599 | 0.940 |
Why?
|
Postmortem Changes | 2 | 2016 | 34 | 0.920 |
Why?
|
Neuropathology | 3 | 2021 | 79 | 0.910 |
Why?
|
Independent Living | 5 | 2021 | 281 | 0.900 |
Why?
|
Wearable Electronic Devices | 5 | 2021 | 40 | 0.770 |
Why?
|
White Matter | 5 | 2018 | 149 | 0.730 |
Why?
|
Male | 37 | 2022 | 15633 | 0.720 |
Why?
|
Female | 37 | 2022 | 16205 | 0.710 |
Why?
|
Autopsy | 9 | 2021 | 335 | 0.650 |
Why?
|
Humans | 49 | 2022 | 29351 | 0.650 |
Why?
|
Diffusion Tensor Imaging | 4 | 2021 | 81 | 0.640 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2018 | 51 | 0.630 |
Why?
|
Aged | 27 | 2022 | 9441 | 0.630 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2018 | 115 | 0.590 |
Why?
|
Range of Motion, Articular | 1 | 2019 | 699 | 0.550 |
Why?
|
Motor Activity | 1 | 2018 | 369 | 0.520 |
Why?
|
Atrophy | 3 | 2021 | 102 | 0.500 |
Why?
|
Thalamus | 3 | 2021 | 28 | 0.500 |
Why?
|
Knee Joint | 1 | 2019 | 797 | 0.450 |
Why?
|
Parkinsonian Disorders | 3 | 2020 | 217 | 0.430 |
Why?
|
Accelerometry | 4 | 2021 | 87 | 0.420 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2019 | 81 | 0.410 |
Why?
|
Walking | 4 | 2022 | 252 | 0.400 |
Why?
|
Neuroimaging | 3 | 2021 | 136 | 0.390 |
Why?
|
Walking Speed | 2 | 2021 | 41 | 0.370 |
Why?
|
Gray Matter | 3 | 2021 | 56 | 0.360 |
Why?
|
Geriatric Assessment | 3 | 2021 | 219 | 0.360 |
Why?
|
Formaldehyde | 1 | 2009 | 14 | 0.350 |
Why?
|
Longitudinal Studies | 7 | 2021 | 1442 | 0.350 |
Why?
|
RNA, Messenger | 2 | 2022 | 326 | 0.340 |
Why?
|
Cohort Studies | 9 | 2020 | 1937 | 0.320 |
Why?
|
Temporal Lobe | 2 | 2020 | 105 | 0.320 |
Why?
|
Brain Mapping | 3 | 2017 | 195 | 0.310 |
Why?
|
Imaging, Three-Dimensional | 3 | 2020 | 222 | 0.300 |
Why?
|
Dementia | 2 | 2022 | 521 | 0.280 |
Why?
|
Parkinson Disease | 4 | 2021 | 1164 | 0.260 |
Why?
|
Organ Size | 3 | 2015 | 107 | 0.260 |
Why?
|
Nerve Net | 2 | 2021 | 54 | 0.230 |
Why?
|
Sclerosis | 3 | 2019 | 68 | 0.230 |
Why?
|
DNA Methylation | 3 | 2019 | 126 | 0.220 |
Why?
|
Transcriptome | 2 | 2022 | 83 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2020 | 96 | 0.220 |
Why?
|
Neuropsychological Tests | 3 | 2022 | 1251 | 0.220 |
Why?
|
Proteome | 1 | 2022 | 39 | 0.210 |
Why?
|
Cerebral Arterial Diseases | 1 | 2021 | 7 | 0.210 |
Why?
|
Tremor | 2 | 2021 | 141 | 0.200 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2021 | 10 | 0.200 |
Why?
|
Proteomics | 1 | 2022 | 91 | 0.200 |
Why?
|
Cerebrovascular Disorders | 1 | 2022 | 132 | 0.200 |
Why?
|
Motor Skills | 1 | 2021 | 61 | 0.200 |
Why?
|
Neuropeptides | 2 | 2019 | 29 | 0.200 |
Why?
|
TDP-43 Proteinopathies | 2 | 2019 | 104 | 0.190 |
Why?
|
Hand Strength | 1 | 2021 | 59 | 0.190 |
Why?
|
Frailty | 1 | 2021 | 38 | 0.190 |
Why?
|
Sarcopenia | 1 | 2021 | 26 | 0.190 |
Why?
|
Gene Expression | 2 | 2019 | 226 | 0.190 |
Why?
|
Cognitive Aging | 1 | 2021 | 81 | 0.190 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 117 | 0.180 |
Why?
|
Adenylate Kinase | 1 | 2019 | 7 | 0.180 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2019 | 19 | 0.180 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 14 | 0.180 |
Why?
|
Neural Stem Cells | 1 | 2019 | 14 | 0.180 |
Why?
|
Brain Ischemia | 1 | 2020 | 71 | 0.180 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 27 | 0.170 |
Why?
|
Genetic Association Studies | 1 | 2019 | 86 | 0.170 |
Why?
|
Cognition Disorders | 3 | 2017 | 1011 | 0.170 |
Why?
|
Disabled Persons | 1 | 2021 | 127 | 0.170 |
Why?
|
Cerebral Cortex | 1 | 2021 | 195 | 0.170 |
Why?
|
Cerebral Hemorrhage | 1 | 2020 | 129 | 0.170 |
Why?
|
Gait Disorders, Neurologic | 1 | 2021 | 144 | 0.170 |
Why?
|
Drug Resistant Epilepsy | 1 | 2018 | 16 | 0.170 |
Why?
|
Memory | 3 | 2017 | 318 | 0.170 |
Why?
|
Electric Stimulation Therapy | 1 | 2018 | 44 | 0.170 |
Why?
|
Bone Resorption | 1 | 2019 | 104 | 0.160 |
Why?
|
Muscle Strength | 1 | 2019 | 127 | 0.160 |
Why?
|
Nerve Fibers | 1 | 2018 | 15 | 0.160 |
Why?
|
Microfilament Proteins | 1 | 2017 | 22 | 0.150 |
Why?
|
Circle of Willis | 1 | 2017 | 6 | 0.150 |
Why?
|
Young Adult | 6 | 2021 | 1933 | 0.150 |
Why?
|
Ultraviolet Therapy | 1 | 2017 | 1 | 0.150 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 50 | 0.150 |
Why?
|
Brain Infarction | 1 | 2017 | 74 | 0.150 |
Why?
|
Linear Models | 2 | 2016 | 254 | 0.150 |
Why?
|
Epithalamus | 1 | 2016 | 3 | 0.150 |
Why?
|
Afferent Pathways | 1 | 2016 | 5 | 0.150 |
Why?
|
Disability Evaluation | 1 | 2019 | 327 | 0.150 |
Why?
|
Sphenoid Sinus | 1 | 2016 | 15 | 0.150 |
Why?
|
Plasmacytoma | 1 | 2016 | 18 | 0.150 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2017 | 46 | 0.150 |
Why?
|
Skin Diseases | 1 | 2017 | 26 | 0.150 |
Why?
|
Nuclear Proteins | 1 | 2017 | 88 | 0.150 |
Why?
|
Femur | 1 | 2020 | 396 | 0.140 |
Why?
|
Adult | 10 | 2021 | 8594 | 0.140 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 173 | 0.140 |
Why?
|
Neurons | 1 | 2019 | 374 | 0.140 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 53 | 0.140 |
Why?
|
Membrane Proteins | 1 | 2017 | 174 | 0.140 |
Why?
|
Neocortex | 1 | 2016 | 34 | 0.140 |
Why?
|
Femoracetabular Impingement | 1 | 2020 | 168 | 0.140 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 340 | 0.130 |
Why?
|
Algorithms | 2 | 2019 | 400 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2016 | 63 | 0.130 |
Why?
|
Joint Instability | 1 | 2019 | 387 | 0.130 |
Why?
|
Middle Aged | 8 | 2021 | 9818 | 0.120 |
Why?
|
Locomotion | 1 | 2014 | 24 | 0.120 |
Why?
|
Shoulder Joint | 1 | 2019 | 572 | 0.110 |
Why?
|
Memory, Episodic | 1 | 2011 | 116 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2010 | 52 | 0.100 |
Why?
|
Mortality | 2 | 2021 | 86 | 0.090 |
Why?
|
Fixatives | 1 | 2009 | 7 | 0.090 |
Why?
|
Sex Factors | 2 | 2021 | 495 | 0.080 |
Why?
|
Risk Factors | 3 | 2021 | 2436 | 0.080 |
Why?
|
Chicago | 2 | 2021 | 865 | 0.080 |
Why?
|
Lewy Bodies | 2 | 2019 | 195 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 254 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 220 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 770 | 0.060 |
Why?
|
Photosensitivity Disorders | 1 | 2003 | 1 | 0.060 |
Why?
|
Sunlight | 1 | 2003 | 3 | 0.060 |
Why?
|
Urticaria | 1 | 2003 | 3 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2019 | 788 | 0.060 |
Why?
|
Adolescent | 3 | 2017 | 2275 | 0.060 |
Why?
|
Depression | 2 | 2017 | 465 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2022 | 26 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2022 | 41 | 0.050 |
Why?
|
Physical Therapy Modalities | 1 | 2022 | 80 | 0.050 |
Why?
|
Executive Function | 1 | 2022 | 121 | 0.050 |
Why?
|
Self-Assessment | 1 | 2021 | 29 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 840 | 0.050 |
Why?
|
Frail Elderly | 1 | 2021 | 51 | 0.050 |
Why?
|
Self Report | 1 | 2021 | 218 | 0.050 |
Why?
|
Fitness Trackers | 1 | 2019 | 13 | 0.040 |
Why?
|
Nestin | 1 | 2019 | 3 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 1829 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2019 | 4 | 0.040 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2019 | 9 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2019 | 21 | 0.040 |
Why?
|
Neurogenesis | 1 | 2019 | 13 | 0.040 |
Why?
|
SNARE Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
Movement | 1 | 2020 | 143 | 0.040 |
Why?
|
Mobility Limitation | 1 | 2020 | 97 | 0.040 |
Why?
|
Epilepsies, Partial | 1 | 2018 | 24 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2019 | 3273 | 0.040 |
Why?
|
Software | 1 | 2019 | 72 | 0.040 |
Why?
|
Life Style | 1 | 2020 | 211 | 0.040 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 60 | 0.040 |
Why?
|
Protein-Arginine Deiminases | 1 | 2017 | 11 | 0.040 |
Why?
|
alpha-Macroglobulins | 1 | 2017 | 12 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 42 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 37 | 0.040 |
Why?
|
Substantia Nigra | 1 | 2019 | 148 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2019 | 688 | 0.040 |
Why?
|
Netrin Receptors | 1 | 2017 | 5 | 0.040 |
Why?
|
Shoulder Injuries | 1 | 2019 | 139 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 958 | 0.040 |
Why?
|
Regression Analysis | 1 | 2018 | 297 | 0.040 |
Why?
|
Age Factors | 1 | 2020 | 839 | 0.040 |
Why?
|
Linkage Disequilibrium | 1 | 2017 | 47 | 0.040 |
Why?
|
Incidence | 1 | 2020 | 752 | 0.040 |
Why?
|
Child | 2 | 2017 | 1345 | 0.040 |
Why?
|
RNA | 1 | 2017 | 39 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2017 | 16 | 0.040 |
Why?
|
Habenula | 1 | 2016 | 3 | 0.040 |
Why?
|
Disease Progression | 1 | 2020 | 788 | 0.040 |
Why?
|
Phototherapy | 1 | 2017 | 37 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 74 | 0.040 |
Why?
|
Activities of Daily Living | 1 | 2020 | 501 | 0.040 |
Why?
|
Alleles | 1 | 2017 | 224 | 0.040 |
Why?
|
Functional Laterality | 1 | 2017 | 91 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2021 | 1111 | 0.040 |
Why?
|
ROC Curve | 1 | 2016 | 138 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 306 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 301 | 0.030 |
Why?
|
Genotype | 1 | 2017 | 405 | 0.030 |
Why?
|
Deep Brain Stimulation | 1 | 2016 | 74 | 0.030 |
Why?
|
Actigraphy | 1 | 2016 | 98 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 1808 | 0.030 |
Why?
|
United States | 1 | 2021 | 2331 | 0.030 |
Why?
|
Prefrontal Cortex | 1 | 2016 | 154 | 0.030 |
Why?
|
Hypokinesia | 1 | 2014 | 27 | 0.030 |
Why?
|
Muscle Rigidity | 1 | 2014 | 26 | 0.030 |
Why?
|
Image Enhancement | 1 | 2013 | 57 | 0.030 |
Why?
|
In Vitro Techniques | 1 | 2013 | 214 | 0.030 |
Why?
|
Sleep | 1 | 2016 | 313 | 0.030 |
Why?
|
Stroke | 1 | 2016 | 293 | 0.030 |
Why?
|
Cadaver | 1 | 2013 | 359 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 552 | 0.030 |
Why?
|
Radiography | 1 | 2009 | 678 | 0.020 |
Why?
|
Child, Preschool | 1 | 2003 | 642 | 0.010 |
Why?
|
Time Factors | 1 | 2003 | 1615 | 0.010 |
Why?
|